These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 2890546

  • 1. Reduction of gastric acidity with ranitidine or famotidine: early evening dosage is more effective than late evening dosage.
    Bauerfeind P, Cilluffo T, Emde C, Fimmel C, Kohler W, Gasser T, Blum AL.
    Digestion; 1987; 37(4):217-22. PubMed ID: 2890546
    [Abstract] [Full Text] [Related]

  • 2. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
    Fiorucci S, Clausi GG, Farinelli M, Santucci L, Farroni F, Pelli MA, Morelli A.
    Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
    [Abstract] [Full Text] [Related]

  • 3. Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers.
    Merki HS, Witzel L, Walt RP, Neumann J, Scheurle E, Mappes A, Krammisch H, Heim J, Kaufmann D, Roehmel J.
    Gut; 1988 Jan; 29(1):81-4. PubMed ID: 2893761
    [Abstract] [Full Text] [Related]

  • 4. Effect of oral famotidine on 24-hour intragastric acidity.
    Santana IA, Lanzon-Miller S, Pounder RE.
    Postgrad Med J; 1986 Jan; 62 Suppl 2():39-42. PubMed ID: 2890150
    [Abstract] [Full Text] [Related]

  • 5. Continuous 24-hour intragastric pH monitoring in the evaluation of the effect of a nightly dose of famotidine, ranitidine and placebo on gastric acidity of patients with duodenal ulcer.
    Savarino V, Mela GS, Scalabrini P, Di Timoteo E, Magnolia MR, Celle G.
    Digestion; 1987 Jan; 37(2):103-9. PubMed ID: 3305114
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.
    Savarino V, Mela GS, Zentilin P, Scalabrini P, Bonifacino G, Gambaro P, Celle G.
    Digestion; 1989 Jan; 42(1):1-6. PubMed ID: 2568299
    [Abstract] [Full Text] [Related]

  • 7. Control of intragastric acidity with over-the-counter doses of ranitidine or famotidine.
    Hamilton MI, Sercombe J, Pounder RE.
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1579-83. PubMed ID: 11563997
    [Abstract] [Full Text] [Related]

  • 8. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
    Savarino V.
    Ital J Gastroenterol; 1990 Oct; 22 Suppl 2():20-3. PubMed ID: 1983412
    [Abstract] [Full Text] [Related]

  • 9. Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring.
    Celle G, Savarino V, Mela GS, Scalabrini P, Sumberaz A, Fera G, Zentilin P.
    Scand J Gastroenterol; 1988 May; 23(4):385-90. PubMed ID: 2898167
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidity.
    Netzer P, Brabetz-Höfliger A, Bründler R, Flogerzi B, Hüsler J, Halter F.
    Aliment Pharmacol Ther; 1998 Apr; 12(4):337-42. PubMed ID: 9690722
    [Abstract] [Full Text] [Related]

  • 11. Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man.
    Grimley CE, West JM, Loft DE, Cottrell J, Mann SG, Stauffer L, Nwokolo CU.
    Aliment Pharmacol Ther; 1996 Oct; 10(5):743-7. PubMed ID: 8899082
    [Abstract] [Full Text] [Related]

  • 12. Does smoking interfere with the effect of histamine H2-receptor antagonists on intragastric acidity in man?
    Bauerfeind P, Cilluffo T, Fimmel CJ, Emde C, von Ritter C, Kohler W, Gugler R, Gasser T, Blum AL.
    Gut; 1987 May; 28(5):549-56. PubMed ID: 3596336
    [Abstract] [Full Text] [Related]

  • 13. Single bedtime dose of famotidine: assessment of its antisecretory action by 24-hour intragastric pH monitoring.
    Savarino V, Picciotto A, Magnolia MR, Scalabrini P, Mela GS, Celle G.
    J Clin Pharmacol; 1987 Oct; 27(10):790-3. PubMed ID: 2892864
    [Abstract] [Full Text] [Related]

  • 14. Single dose treatment with H2 receptor antagonists: is bedtime administration too late?
    Merki H, Witzel L, Harre K, Scheurle E, Neumann J, Röhmel J.
    Gut; 1987 Apr; 28(4):451-4. PubMed ID: 3583073
    [Abstract] [Full Text] [Related]

  • 15. Nocturnal intragastric acidity after over-the-counter doses of famotidine, ranitidine or placebo.
    Grimley CE, Cottrell J, Mann SG, Stauffer L, Nwokolo CU.
    Aliment Pharmacol Ther; 1997 Oct; 11(5):881-5. PubMed ID: 9354196
    [Abstract] [Full Text] [Related]

  • 16. Gastric and esophageal acidity during continuous treatment with H2-antagonists in uncomplicated esophagitis.
    Fiorucci S, Santucci L, Perrone E, Abbritti F, Morelli A.
    Scand J Gastroenterol; 1989 Aug; 24(6):671-7. PubMed ID: 2573143
    [Abstract] [Full Text] [Related]

  • 17. Low-dose famotidine and ranitidine as single post-prandial doses: a three-period placebo-controlled comparative trial.
    Reilly TG, Singh S, Cottrell J, Mann SG, Stauffer L, Walt RP.
    Aliment Pharmacol Ther; 1996 Oct; 10(5):749-55. PubMed ID: 8899083
    [Abstract] [Full Text] [Related]

  • 18. Duration of acid suppression in H2-antagonist nonresponders.
    Savarino V, Mela GS, Zentilin P, Cutela P, Mele MR, Celle G.
    Digestion; 1992 Oct; 51(4):185-92. PubMed ID: 1356863
    [Abstract] [Full Text] [Related]

  • 19. Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration.
    Lachman L, Howden CW.
    Am J Gastroenterol; 2000 Jan; 95(1):57-61. PubMed ID: 10638559
    [Abstract] [Full Text] [Related]

  • 20. Impact of food intake on the antisecretory effect of low-dose ranitidine and famotidine.
    Netzer P, Eschenmoser K, Halter F, Inauen W.
    Aliment Pharmacol Ther; 1999 Mar; 13(3):407-12. PubMed ID: 10102975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.